Show simple item record

dc.contributor.authorKhankhanian, Pouya
dc.contributor.authorMatsushita, Takuya
dc.contributor.authorMadireddy, Lohith
dc.contributor.authorLizée, Antoine
dc.contributor.authorDin, Lennox
dc.contributor.authorMoré, Jayaji M
dc.contributor.authorGourraud, Pierre-Antoine
dc.contributor.authorHauser, Stephen L
dc.contributor.authorBaranzini, Sergio E
dc.contributor.authorOksenberg, Jorge R
dc.date.accessioned2015-09-01T16:43:23Z
dc.date.available2015-09-01T16:43:23Z
dc.date.issued2015-07-28
dc.identifier.citationBMC Medical Genetics. 2015 Jul 28;16(1):55
dc.identifier.urihttp://dx.doi.org/10.1186/s12881-015-0201-2
dc.identifier.urihttp://hdl.handle.net/10724/31648
dc.description.abstractAbstract Background Multiple sclerosis (MS) is an autoimmune disease of the central nervous system, with a strong genetic component. Over 100 genetic loci have been implicated in susceptibility to MS in European populations, the most prominent being the 15:01 allele of the HLA-DRB1 gene. The prevalence of MS is high in European populations including those of Ashkenazi origin, and low in African and Asian populations including those of Jewish origin. Methods Here we identified and extracted a total of 213 Ashkenazi MS cases and 546 ethnically matched healthy control individuals from two previous genome-wide case-control association analyses, and 72 trios (affected proband and two unaffected parents) from a previous genome-wide transmission disequilibrium association study, using genetic data to define Ashkenazi. We compared the pattern of genetic risk between Ashkenazi and non-Ashkenazi Europeans. We also sought to identify novel Ashkenazi-specific risk loci by performing association tests on the subset of Ashkenazi cases, controls, probands, and parents from each study. Results The HLA-DRB1*15:01 allele and the non-HLA risk alleles were present at relatively low frequencies among Ashkenazi and explained a smaller fraction of the population-level risk when compared to non-Ashkenazi Europeans. Alternative HLA susceptibility alleles were identified in an Ashkenazi-only association study, including HLA-A*68:02 and one or both genes in the HLA-B*38:01-HLA-C*12:03 haplotype. The genome-wide screen in Ashkenazi did not reveal any loci associated with MS risk. Conclusion These results suggest that genetic susceptibility to MS in Ashkenazi Jews has not been as well established as that of non-Ashkenazi Europeans. This implies value in studying large well-characterized Ashkenazi populations to accelerate gene discovery in complex genetic diseases.
dc.titleGenetic contribution to multiple sclerosis risk among Ashkenazi Jews
dc.typeJournal Article
dc.date.updated2015-07-29T18:03:44Z
dc.language.rfc3066en
dc.rights.holderKhankhanian et al.


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record